We are live on ! Find out more
SRIM

Saratoga Research & Investment Management Portfolio holdings

AUM $1.83B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+3.82%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$1.59B
AUM Growth
+$126M
Cap. Flow
+$73.6M
Cap. Flow %
4.63%
Top 10 Hldgs %
54.92%
Holding
46
New
2
Increased
25
Reduced
11
Closed
1

Top Buys

Rank Stock Value
1
MMM icon
3M
MMM
+$35.8M
2
BIIB icon
Biogen
BIIB
+$18.3M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$3.51M
4
CHRW icon
C.H. Robinson
CHRW
+$3.35M
5
RTX icon
RTX Corp
RTX
+$3.26M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.63M
2
DEO icon
Diageo
DEO
+$1.44M
3
VAR
Varian Medical Systems, Inc.
VAR
+$1.03M
4
WMT icon
Walmart Inc
WMT
+$1.02M
5
KO icon
Coca-Cola
KO
+$1M

Sector Composition

Rank Sector Weight
1 Technology 32.42%
2 Healthcare 14.58%
3 Industrials 13.97%
4 Consumer Staples 12.18%
5 Consumer Discretionary 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.47T
$118M 7.42%
2,383,412
+36,400
+2% +$1.77M
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.11T
$100M 6.29%
469,160
+16,970
+4% +$3.51M
RTX icon
3
RTX Corp
RTX
$302B
$97.7M 6.14%
1,191,979
+39,032
+3% +$3.26M
ORCL icon
4
Oracle
ORCL
$418B
$93.5M 5.88%
1,640,356
+12,014
+0.7% +$650K
DIS icon
5
Walt Disney
DIS
$178B
$91.8M 5.77%
657,238
+8,506
+1% +$1.13M
CSCO icon
6
Cisco
CSCO
$476B
$85.6M 5.39%
1,564,780
-5,863
-0.4% -$324K
NVO
7
Novo Nordisk
NVO
$206B
$79.1M 4.97%
3,098,938
+78,246
+3% +$1.93M
MSFT icon
8
Microsoft
MSFT
$3.74T
$73.4M 4.61%
547,709
-28,628
-5% -$3.63M
WMT icon
9
Walmart Inc
WMT
$895B
$70.8M 4.45%
1,921,563
-29,514
-2% -$1.02M
IBM icon
10
IBM
IBM
$224B
$63.6M 4%
482,256
+19,059
+4% +$2.5M
PG icon
11
Procter & Gamble
PG
$336B
$58.3M 3.67%
531,885
-901
-0.2% -$96K
CHRW icon
12
C.H. Robinson
CHRW
$16.9B
$58M 3.65%
687,886
+39,886
+6% +$3.35M
SBUX icon
13
Starbucks
SBUX
$121B
$57.5M 3.62%
686,410
-9,812
-1% -$769K
BIIB icon
14
Biogen
BIIB
$30.3B
$56.1M 3.53%
239,987
+79,307
+49% +$18.3M
NKE icon
15
Nike
NKE
$60.8B
$55.1M 3.46%
656,288
+7,343
+1% +$618K
CTSH icon
16
Cognizant
CTSH
$26.4B
$54M 3.39%
851,133
+44,608
+6% +$2.93M
MDT icon
17
Medtronic
MDT
$115B
$39.1M 2.46%
401,331
+12,795
+3% +$1.17M
PEP icon
18
PepsiCo
PEP
$188B
$38.4M 2.42%
292,868
+4,486
+2% +$575K
GOOGL icon
19
Alphabet (Google) Class A
GOOGL
$4.25T
$36.3M 2.28%
670,320
+43,860
+7% +$2.54M
MMM icon
20
3M
MMM
$94.4B
$33.7M 2.12%
+232,562
New +$35.8M
EXPD icon
21
Expeditors International
EXPD
$23.1B
$32.7M 2.05%
430,724
-3,161
-0.7% -$239K
VAR
22
DELISTED
Varian Medical Systems, Inc.
VAR
$31.4M 1.97%
230,461
-7,734
-3% -$1.03M
JNJ icon
23
Johnson & Johnson
JNJ
$625B
$30.6M 1.92%
219,561
+2,976
+1% +$412K
ACN icon
24
Accenture
ACN
$109B
$26.7M 1.68%
144,245
-4,006
-3% -$719K
KO icon
25
Coca-Cola
KO
$373B
$25.9M 1.63%
508,583
-20,432
-4% -$1M
1
2

Similar funds

SI
Standard Investments New York $1.83B AUM 4.12% 1-Year Est. Return
KAM
Kensington Asset Management Austin, Texas $1.84B AUM 13.95% 1-Year Est. Return
DWT
Dorsey & Whitney Trust Sioux Falls, South Dakota $1.82B AUM 19.69% 1-Year Est. Return
OQS
Occudo Quantitative Strategies Fort Lauderdale, Florida $1.84B AUM 22.15% 1-Year Est. Return
RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
ABTD
Arvest Bank Trust Division Dewey, Oklahoma $1.84B AUM 20.84% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.84B AUM 13.39% 1-Year Est. Return

Saratoga Research & Investment Management's Q2 2019 Portfolio in Review

As of Q2 2019, Saratoga Research & Investment Management held 46 positions worth $1.59B, up 8.6% from $1.46B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Saratoga Research & Investment Management deployed $73.6M of net new capital in Q2 2019, opening 2 new positions and adding to 25 existing holdings. Its largest new stake was 3M: 232,562 shares worth $33.7M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Microsoft, an estimated $3.63M trimmed.

  • Saratoga Research & Investment Management's largest Q2 2019 buy was 3M: 232,562 shares worth $33.7M.
  • Saratoga Research & Investment Management added most to Biogen in Q2 2019, an estimated $18.3M increase.
  • Saratoga Research & Investment Management's biggest Q2 2019 reduction was Microsoft, cutting an estimated $3.63M.
  • Saratoga Research & Investment Management fully exited Diageo in Q2 2019, selling an estimated $1.44M.
  • Saratoga Research & Investment Management's ten largest holdings make up 55% of its $1.59B portfolio in Q2 2019.
  • Saratoga Research & Investment Management opened 2 new positions and closed 1 in Q2 2019.
  • Saratoga Research & Investment Management's portfolio value rose 8.6% quarter-over-quarter to $1.59B.

Based on Saratoga Research & Investment Management's 13F filing for Q2 2019, filed 24 Jul 2019.